Table of Content

1 Chagas Disease Drug Market Overview
1.1 Chagas Disease Drug Product Scope
1.2 Chagas Disease Drug Segment by Type
1.2.1 Global Chagas Disease Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Cz-007
1.2.3 Cz-008
1.2.4 D-121
1.2.5 DNDI-0690
1.2.6 EPLBS-1246
1.2.7 EPLBS-967
1.2.8 Others
1.3 Chagas Disease Drug Segment by Application
1.3.1 Global Chagas Disease Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Chagas Disease Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Chagas Disease Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Chagas Disease Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Chagas Disease Drug Price Trends (2016-2027)

2 Chagas Disease Drug Estimates and Forecasts by Region
2.1 Global Chagas Disease Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Chagas Disease Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Chagas Disease Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Chagas Disease Drug Revenue Market Share by Region (2016-2021)
2.3 Global Chagas Disease Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Chagas Disease Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Chagas Disease Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Chagas Disease Drug Estimates and Projections (2016-2027)
2.4.2 Europe Chagas Disease Drug Estimates and Projections (2016-2027)
2.4.3 China Chagas Disease Drug Estimates and Projections (2016-2027)
2.4.4 Japan Chagas Disease Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Chagas Disease Drug Estimates and Projections (2016-2027)
2.4.6 India Chagas Disease Drug Estimates and Projections (2016-2027)

3 Global Chagas Disease Drug Competition Landscape by Players
3.1 Global Top Chagas Disease Drug Players by Sales (2016-2021)
3.2 Global Top Chagas Disease Drug Players by Revenue (2016-2021)
3.3 Global Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chagas Disease Drug as of 2020)
3.4 Global Chagas Disease Drug Average Price by Company (2016-2021)
3.5 Manufacturers Chagas Disease Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Chagas Disease Drug Market Size by Type
4.1 Global Chagas Disease Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Chagas Disease Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Chagas Disease Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Chagas Disease Drug Price by Type (2016-2021)
4.2 Global Chagas Disease Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Chagas Disease Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Chagas Disease Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Chagas Disease Drug Price Forecast by Type (2022-2027)

5 Global Chagas Disease Drug Market Size by Application
5.1 Global Chagas Disease Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Chagas Disease Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Chagas Disease Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Chagas Disease Drug Price by Application (2016-2021)
5.2 Global Chagas Disease Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Chagas Disease Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Chagas Disease Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Chagas Disease Drug Price Forecast by Application (2022-2027)

6 North America Chagas Disease Drug Market Facts & Figures
6.1 North America Chagas Disease Drug Sales by Company
6.1.1 North America Chagas Disease Drug Sales by Company (2016-2021)
6.1.2 North America Chagas Disease Drug Revenue by Company (2016-2021)
6.2 North America Chagas Disease Drug Sales Breakdown by Type
6.2.1 North America Chagas Disease Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Chagas Disease Drug Sales Breakdown by Type (2022-2027)
6.3 North America Chagas Disease Drug Sales Breakdown by Application
6.3.1 North America Chagas Disease Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Chagas Disease Drug Sales Breakdown by Application (2022-2027)

7 Europe Chagas Disease Drug Market Facts & Figures
7.1 Europe Chagas Disease Drug Sales by Company
7.1.1 Europe Chagas Disease Drug Sales by Company (2016-2021)
7.1.2 Europe Chagas Disease Drug Revenue by Company (2016-2021)
7.2 Europe Chagas Disease Drug Sales Breakdown by Type
7.2.1 Europe Chagas Disease Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Chagas Disease Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Chagas Disease Drug Sales Breakdown by Application
7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)

8 China Chagas Disease Drug Market Facts & Figures
8.1 China Chagas Disease Drug Sales by Company
8.1.1 China Chagas Disease Drug Sales by Company (2016-2021)
8.1.2 China Chagas Disease Drug Revenue by Company (2016-2021)
8.2 China Chagas Disease Drug Sales Breakdown by Type
8.2.1 China Chagas Disease Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Chagas Disease Drug Sales Breakdown by Type (2022-2027)
8.3 China Chagas Disease Drug Sales Breakdown by Application
8.3.1 China 153 Sales Breakdown by Application (2016-2021)
8.3.2 China 153 Sales Breakdown by Application (2022-2027)

9 Japan Chagas Disease Drug Market Facts & Figures
9.1 Japan Chagas Disease Drug Sales by Company
9.1.1 Japan Chagas Disease Drug Sales by Company (2016-2021)
9.1.2 Japan Chagas Disease Drug Revenue by Company (2016-2021)
9.2 Japan Chagas Disease Drug Sales Breakdown by Type
9.2.1 Japan Chagas Disease Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Chagas Disease Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Chagas Disease Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Chagas Disease Drug Market Facts & Figures
10.1 Southeast Asia Chagas Disease Drug Sales by Company
10.1.1 Southeast Asia Chagas Disease Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Chagas Disease Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Chagas Disease Drug Sales Breakdown by Type
10.2.1 Southeast Asia Chagas Disease Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Chagas Disease Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Chagas Disease Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Chagas Disease Drug Market Facts & Figures
11.1 India Chagas Disease Drug Sales by Company
11.1.1 India Chagas Disease Drug Sales by Company (2016-2021)
11.1.2 India Chagas Disease Drug Revenue by Company (2016-2021)
11.2 India Chagas Disease Drug Sales Breakdown by Type
11.2.1 India Chagas Disease Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Chagas Disease Drug Sales Breakdown by Type (2022-2027)
11.3 India Chagas Disease Drug Sales Breakdown by Application
11.3.1 India Chagas Disease Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Chagas Disease Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Chagas Disease Drug Business
12.1 AstraZeneca Plc
12.1.1 AstraZeneca Plc Corporation Information
12.1.2 AstraZeneca Plc Business Overview
12.1.3 AstraZeneca Plc Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Plc Chagas Disease Drug Products Offered
12.1.5 AstraZeneca Plc Recent Development
12.2 Bayer AG
12.2.1 Bayer AG Corporation Information
12.2.2 Bayer AG Business Overview
12.2.3 Bayer AG Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer AG Chagas Disease Drug Products Offered
12.2.5 Bayer AG Recent Development
12.3 Daiichi Sankyo Co Ltd
12.3.1 Daiichi Sankyo Co Ltd Corporation Information
12.3.2 Daiichi Sankyo Co Ltd Business Overview
12.3.3 Daiichi Sankyo Co Ltd Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Daiichi Sankyo Co Ltd Chagas Disease Drug Products Offered
12.3.5 Daiichi Sankyo Co Ltd Recent Development
12.4 Eisai Co Ltd
12.4.1 Eisai Co Ltd Corporation Information
12.4.2 Eisai Co Ltd Business Overview
12.4.3 Eisai Co Ltd Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Eisai Co Ltd Chagas Disease Drug Products Offered
12.4.5 Eisai Co Ltd Recent Development
12.5 GlaxoSmithKline Plc
12.5.1 GlaxoSmithKline Plc Corporation Information
12.5.2 GlaxoSmithKline Plc Business Overview
12.5.3 GlaxoSmithKline Plc Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GlaxoSmithKline Plc Chagas Disease Drug Products Offered
12.5.5 GlaxoSmithKline Plc Recent Development
12.6 Grupo Praxis Pharmaceutical SA
12.6.1 Grupo Praxis Pharmaceutical SA Corporation Information
12.6.2 Grupo Praxis Pharmaceutical SA Business Overview
12.6.3 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Products Offered
12.6.5 Grupo Praxis Pharmaceutical SA Recent Development
12.7 Humanigen Inc
12.7.1 Humanigen Inc Corporation Information
12.7.2 Humanigen Inc Business Overview
12.7.3 Humanigen Inc Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Humanigen Inc Chagas Disease Drug Products Offered
12.7.5 Humanigen Inc Recent Development
12.8 Kancera AB
12.8.1 Kancera AB Corporation Information
12.8.2 Kancera AB Business Overview
12.8.3 Kancera AB Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Kancera AB Chagas Disease Drug Products Offered
12.8.5 Kancera AB Recent Development
12.9 Merck & Co Inc
12.9.1 Merck & Co Inc Corporation Information
12.9.2 Merck & Co Inc Business Overview
12.9.3 Merck & Co Inc Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Merck & Co Inc Chagas Disease Drug Products Offered
12.9.5 Merck & Co Inc Recent Development
12.10 Novartis AG
12.10.1 Novartis AG Corporation Information
12.10.2 Novartis AG Business Overview
12.10.3 Novartis AG Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novartis AG Chagas Disease Drug Products Offered
12.10.5 Novartis AG Recent Development
12.11 Oblita Therapeutics BVBA
12.11.1 Oblita Therapeutics BVBA Corporation Information
12.11.2 Oblita Therapeutics BVBA Business Overview
12.11.3 Oblita Therapeutics BVBA Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Oblita Therapeutics BVBA Chagas Disease Drug Products Offered
12.11.5 Oblita Therapeutics BVBA Recent Development
12.12 Sanofi
12.12.1 Sanofi Corporation Information
12.12.2 Sanofi Business Overview
12.12.3 Sanofi Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Sanofi Chagas Disease Drug Products Offered
12.12.5 Sanofi Recent Development

13 Chagas Disease Drug Manufacturing Cost Analysis
13.1 Chagas Disease Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Chagas Disease Drug
13.4 Chagas Disease Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Chagas Disease Drug Distributors List
14.3 Chagas Disease Drug Customers

15 Market Dynamics
15.1 Chagas Disease Drug Market Trends
15.2 Chagas Disease Drug Drivers
15.3 Chagas Disease Drug Market Challenges
15.4 Chagas Disease Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Chagas Disease Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Chagas Disease Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Chagas Disease Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Chagas Disease Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Chagas Disease Drug Sales Market Share by Region (2016-2021)
Table 6. Global Chagas Disease Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Chagas Disease Drug Revenue Share by Region (2016-2021)
Table 8. Global Chagas Disease Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Chagas Disease Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Chagas Disease Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Chagas Disease Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Chagas Disease Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Chagas Disease Drug Sales Share by Company (2016-2021)
Table 14. Global Chagas Disease Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Chagas Disease Drug Revenue Share by Company (2016-2021)
Table 16. Global Chagas Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chagas Disease Drug as of 2020)
Table 17. Global Chagas Disease Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Chagas Disease Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Chagas Disease Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Chagas Disease Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Chagas Disease Drug Sales Share by Type (2016-2021)
Table 23. Global Chagas Disease Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Chagas Disease Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Chagas Disease Drug Sales Share by Type (2022-2027)
Table 26. Global Chagas Disease Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Chagas Disease Drug Revenue Share by Type (2022-2027)
Table 28. Global Chagas Disease Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Chagas Disease Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Chagas Disease Drug Sales Share by Application (2016-2021)
Table 31. Global Chagas Disease Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Chagas Disease Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Chagas Disease Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Chagas Disease Drug Sales Share by Application (2022-2027)
Table 35. Global Chagas Disease Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Chagas Disease Drug Revenue Share by Application (2022-2027)
Table 37. Global Chagas Disease Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Chagas Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Chagas Disease Drug Sales Market Share by Company (2016-2021)
Table 40. North America Chagas Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Chagas Disease Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Chagas Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Chagas Disease Drug Sales Market Share by Type (2016-2021)
Table 44. North America Chagas Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Chagas Disease Drug Sales Market Share by Type (2022-2027)
Table 46. North America Chagas Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Chagas Disease Drug Sales Market Share by Application (2016-2021)
Table 48. North America Chagas Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Chagas Disease Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Chagas Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Chagas Disease Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Chagas Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Chagas Disease Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Chagas Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Chagas Disease Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Chagas Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Chagas Disease Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Chagas Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Chagas Disease Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Chagas Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Chagas Disease Drug Sales Market Share by Application (2022-2027)
Table 62. China Chagas Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Chagas Disease Drug Sales Market Share by Company (2016-2021)
Table 64. China Chagas Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Chagas Disease Drug Revenue Market Share by Company (2016-2021)
Table 66. China Chagas Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Chagas Disease Drug Sales Market Share by Type (2016-2021)
Table 68. China Chagas Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Chagas Disease Drug Sales Market Share by Type (2022-2027)
Table 70. China Chagas Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Chagas Disease Drug Sales Market Share by Application (2016-2021)
Table 72. China Chagas Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Chagas Disease Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Chagas Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Chagas Disease Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Chagas Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Chagas Disease Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Chagas Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Chagas Disease Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Chagas Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Chagas Disease Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Chagas Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Chagas Disease Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Chagas Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Chagas Disease Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Chagas Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Chagas Disease Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Chagas Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Chagas Disease Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Chagas Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Chagas Disease Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Chagas Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Chagas Disease Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Chagas Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Chagas Disease Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Chagas Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Chagas Disease Drug Sales Market Share by Application (2022-2027)
Table 98. India Chagas Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Chagas Disease Drug Sales Market Share by Company (2016-2021)
Table 100. India Chagas Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Chagas Disease Drug Revenue Market Share by Company (2016-2021)
Table 102. India Chagas Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Chagas Disease Drug Sales Market Share by Type (2016-2021)
Table 104. India Chagas Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Chagas Disease Drug Sales Market Share by Type (2022-2027)
Table 106. India Chagas Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Chagas Disease Drug Sales Market Share by Application (2016-2021)
Table 108. India Chagas Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Chagas Disease Drug Sales Market Share by Application (2022-2027)
Table 110. AstraZeneca Plc Corporation Information
Table 111. AstraZeneca Plc Description and Business Overview
Table 112. AstraZeneca Plc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. AstraZeneca Plc Chagas Disease Drug Product
Table 114. AstraZeneca Plc Recent Development
Table 115. Bayer AG Corporation Information
Table 116. Bayer AG Description and Business Overview
Table 117. Bayer AG Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Bayer AG Chagas Disease Drug Product
Table 119. Bayer AG Recent Development
Table 120. Daiichi Sankyo Co Ltd Corporation Information
Table 121. Daiichi Sankyo Co Ltd Description and Business Overview
Table 122. Daiichi Sankyo Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Daiichi Sankyo Co Ltd Chagas Disease Drug Product
Table 124. Daiichi Sankyo Co Ltd Recent Development
Table 125. Eisai Co Ltd Corporation Information
Table 126. Eisai Co Ltd Description and Business Overview
Table 127. Eisai Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Eisai Co Ltd Chagas Disease Drug Product
Table 129. Eisai Co Ltd Recent Development
Table 130. GlaxoSmithKline Plc Corporation Information
Table 131. GlaxoSmithKline Plc Description and Business Overview
Table 132. GlaxoSmithKline Plc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. GlaxoSmithKline Plc Chagas Disease Drug Product
Table 134. GlaxoSmithKline Plc Recent Development
Table 135. Grupo Praxis Pharmaceutical SA Corporation Information
Table 136. Grupo Praxis Pharmaceutical SA Description and Business Overview
Table 137. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product
Table 139. Grupo Praxis Pharmaceutical SA Recent Development
Table 140. Humanigen Inc Corporation Information
Table 141. Humanigen Inc Description and Business Overview
Table 142. Humanigen Inc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Humanigen Inc Chagas Disease Drug Product
Table 144. Humanigen Inc Recent Development
Table 145. Kancera AB Corporation Information
Table 146. Kancera AB Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Kancera AB Description and Business Overview
Table 148. Kancera AB Chagas Disease Drug Product
Table 149. Kancera AB Recent Development
Table 150. Merck & Co Inc Corporation Information
Table 151. Merck & Co Inc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Merck & Co Inc Description and Business Overview
Table 153. Merck & Co Inc Chagas Disease Drug Product
Table 154. Merck & Co Inc Recent Development
Table 155. Novartis AG Corporation Information
Table 156. Novartis AG Description and Business Overview
Table 157. Novartis AG Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Novartis AG Chagas Disease Drug Product
Table 159. Novartis AG Recent Development
Table 160. Oblita Therapeutics BVBA Corporation Information
Table 161. Oblita Therapeutics BVBA Description and Business Overview
Table 162. Oblita Therapeutics BVBA Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Oblita Therapeutics BVBA Chagas Disease Drug Product
Table 164. Oblita Therapeutics BVBA Recent Development
Table 165. Sanofi Corporation Information
Table 166. Sanofi Description and Business Overview
Table 167. Sanofi Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Sanofi Chagas Disease Drug Product
Table 169. Sanofi Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Chagas Disease Drug Distributors List
Table 173. Chagas Disease Drug Customers List
Table 174. Chagas Disease Drug Market Trends
Table 175. Chagas Disease Drug Market Drivers
Table 176. Chagas Disease Drug Market Challenges
Table 177. Chagas Disease Drug Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Chagas Disease Drug Product Picture
Figure 2. Global Chagas Disease Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Cz-007 Product Picture
Figure 4. Cz-008 Product Picture
Figure 5. D-121 Product Picture
Figure 6. DNDI-0690 Product Picture
Figure 7. EPLBS-1246 Product Picture
Figure 8. EPLBS-967 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Chagas Disease Drug Sales Market Share by Application in 2021 & 2027
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Others Examples
Figure 14. Global Chagas Disease Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Chagas Disease Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global Chagas Disease Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 17. Global Chagas Disease Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 18. Global Chagas Disease Drug Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global Chagas Disease Drug Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America Chagas Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. North America Chagas Disease Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 22. Europe Chagas Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Europe Chagas Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 24. China Chagas Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. China Chagas Disease Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 26. Japan Chagas Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Japan Chagas Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Chagas Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Chagas Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 30. India Chagas Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. India Chagas Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 32. Global 5 Largest Chagas Disease Drug Players Market Share by Revenue in Chagas Disease Drug: 2016 & 2020
Figure 33. Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 34. Global Chagas Disease Drug Revenue Share by Type (2016-2021)
Figure 35. Global Chagas Disease Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Global Chagas Disease Drug Revenue Share by Application (2016-2021)
Figure 37. Global Chagas Disease Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Chagas Disease Drug Sales Market Share by Type in 2020
Figure 39. North America Chagas Disease Drug Sales Market Share by Application in 2020
Figure 40. Europe Chagas Disease Drug Sales Market Share by Type in 2020
Figure 41. Europe Chagas Disease Drug Sales Market Share by Application in 2020
Figure 42. China Chagas Disease Drug Sales Market Share by Type in 2020
Figure 43. China Chagas Disease Drug Sales Market Share by Application in 2020
Figure 44. Japan Chagas Disease Drug Sales Market Share by Type in 2020
Figure 45. Japan Chagas Disease Drug Sales Market Share by Application in 2020
Figure 46. Southeast Asia Chagas Disease Drug Sales Market Share by Type in 2020
Figure 47. Southeast Asia Chagas Disease Drug Sales Market Share by Application in 2020
Figure 48. India Chagas Disease Drug Sales Market Share by Type in 2020
Figure 49. India Chagas Disease Drug Sales Market Share by Application in 2020
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Chagas Disease Drug
Figure 52. Manufacturing Process Analysis of Chagas Disease Drug
Figure 53. Chagas Disease Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed